13G Filing: Broadfin Capital and Aratana Therapeutics Inc. (PETX)

Page 5 of 10

Page 5 of 10 – SEC Filing

CUSIP No
03874P101
Item 1.
(a).
Name of Issuer:
Aratana Therapeutics, Inc.
(b).
Address of Issuer’s Principal Executive Offices:
11400 Tomahawk Creek Parkway, Suite 340
Leawood, Kansas 66211
Item 2.
(a).
Name of Person Filing:
Broadfin Capital, LLC
Broadfin Healthcare Master Fund, Ltd.
Kevin Kotler
(b).
Address of Principal Business Office, or if None, Residence:
Broadfin Capital, LLC
300 Park Avenue, 25th Floor
New York, New York 10022
United States of America
Broadfin Healthcare Master Fund, Ltd.
20 Genesis Close
Ansbacher House, Second Floor
P.O. Box 1344
Grand Cayman KY1-1108
Cayman Islands
Kevin Kotler
c/o Broadfin Capital, LLC
300 Park Avenue, 25th Floor
New York, New York 10022
United States of America
(c)
Citizenship:
Broadfin Capital, LLC – Delaware
Broadfin Healthcare Master Fund, Ltd. – Cayman Islands
Kevin Kotler – United States of America
(d).
Title of Class of Securities:
Common Stock, $0.001 par value
(e).
CUSIP Number:
03874P101
Item 3.
This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
(a)
[_]
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
(b)
[_]
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
(d)
[_]
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[_]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
[_]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i)
[_]
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[_]
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

Follow Aratana Therapeutics Inc. (NASDAQ:PETX)

Page 5 of 10